ICAP Patent Brokerage Announces Sale of Remote Access Life-Saving Telemedicine Information Patent

SAN FRANCISCO, Sept. 27, 2012 /PRNewswire/ -- ICAP Patent Brokerage announces the sale of one US granted medical technology patent for a life-saving product that gathers important diagnostic data on a patient experiencing a medical emergency or other medical condition in the field. First responders, rural health care providers, or those located in non-medical institutions are able to transmit the data to centrally located health care providers who can assist in providing real-time critical care or other medical support to help stabilize and treat patients in remote locations including helping to determine a medical plan if one is indicated.

(Logo: http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

"Nothing is more important to providing remote critical care than to have access to a patient's medical condition and diagnostic testing at the actual time of a medical intervention or assessment.  Timely medical status information can save lives. Accordingly, we're very excited about offering this telemedicine tool to our global base of buyers," says Dean Becker, CEO ICAP Patent Brokerage and ICAP Ocean Tomo Auctions.

Key Characteristics & Benefits

This IP device eliminates barriers to medical care related to distance medicine, allowing physicians and nurses to examine, diagnose, and treat subjects remotely through telemedicine technology. This portable device contains a broad spectrum of data-gathering instruments for real-time physical examinations, including ophthalmoscopes and otoscopes for visual inspection, electronic stethoscopes for audio evaluation, oximeters and ECG monitors for electrical observation, and visual imaging capabilities. The results from these tests are immediately transmitted to medical personnel including emergency personnel, medical specialists, and other medical providers using a telecommunications system contained in the portable device. This means that fewer physicians may attend to a greater number of patients, and also provide care to those that find themselves in desperate situations.

The patent will be sold to the party who provides the highest offer on or before October 31st, subject to trustee and bankruptcy court approval.

Technical description for this intellectual property portfolio.

To learn more about the assets available for sale in this portfolio:

Contact Paul Greco of ICAP Patent Brokerage at (212) 815-6692 or via email at [email protected].

Follow us on Twitter (@ICAP_Auction_IP) and join our LinkedIn group.

About ICAP Patent Brokerage

ICAP Patent Brokerage is a division of ICAP plc and the world's largest intellectual property brokerage and patent auction firm.

About ICAP

ICAP is the world's leading interdealer broker and provider of post trade risk and information services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, FX, emerging markets and equity derivatives through voice and electronic networks. Through our post trade risk and information services we help our customers manage and mitigate risks in their portfolios. For more information, go to www.icap.com.

SOURCE ICAP Patent Brokerage

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED